TO PROVIDE SEQUENCING SERVICES USING WHOLE GENOME SEQUENCING (GERMLINE FFPE) FOR NCI (KLEIN)
TO PROVIDE SEQUENCING SERVICES USING WHOLE GENOME SEQUENCING (GERMLINE FFPE) FOR NCI (KLEIN)
批准号:
10949135
负责人:
KIM DOHENY
金额:
$77.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-27 至 2025-12-31
中文摘要
标题:非裔美国人前列腺癌根治术队列中前列腺癌生存的遗传预测因素:
遗传病研究中心(CIDR)跨NIH合作遗传病研究中心(CIDR)代表着NCI和NHGRI之间的重要合作。自1996年以来,美国国立卫生研究院参加了与约翰·霍普金斯大学的CIDR合同。这一跨NIH合作由10个IC支持,NHGRI是主要IC。CIDR为美国国立卫生研究院资助的受赠者提供最先进的基因组学和统计遗传学服务,包括全基因组和全外显子组测序、全基因组关联研究和甲基化分析。除了提供出色的基因组学服务外,CIDR还为NIH的受赠者提供研究设计和统计分析方面的咨询。继续这种合作的一个主要原因是,由于CIDR提供的基因组学数据,对遗传病/疾病的重要新见解可能会推动一个研究领域的发展。此外,CIDR产生的数据需要存放在DBGaP中,以便这些数据可供广大科学界进一步分析。所有通过NIH资助的CIDR计划申请访问权限的调查人员都必须向NIH提交电子申请。X01申请持续接受,并由CIDR访问委员会对其科学价值进行评估。CIDR理事会由支持CIC的代表组成,是第二级审查机构,负责确定哪些项目有权使用CIDR设施。
英文摘要
Title: Genetic Predictors of Prostate Cancer Survival in an African American Radical Prostatectomy Cohort:
Center for Inherited Disease Research (CIDR) Trans-NIH Collaboration The Center for Inherited Disease Research (CIDR) represents an important collaboration between NCI and NHGRI. Since 1996, Institutes of the NIH have participated in the CIDR contract with the Johns Hopkins University. This trans-NIH collaboration is supported by 10 ICs, with NHGRI serving as the lead IC. CIDR provides to NIH-supported grantees state-of-the-art genomics and statistical genetics services, including whole genome and whole exome sequencing, genome-wide association studies (GWAS) and methylation analysis. In addition to providing outstanding genomics services, CIDR also consults on study design and statistical analysis to NIH grantees. A prime reason for continuing this collaboration is that, as a result of the genomics data provided by CIDR, important new insights into genetic diseases/conditions can potentially move a field of research forward. In addition, the data produced by CIDR is required to be deposited in dbGaP so that the data will be available for further analysis by the scientific community at large. All investigators requesting access through the NIH-funded CIDR Program must submit an electronic application to NIH. X01 applications are continuously accepted and are evaluated for scientific merit by the CIDR Access Committee. The CIDR Board of Governors, which is made up of representatives from the supporting ICs, serves as the second level of review and determines which projects are granted access to the CIDR facility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRETESTING: UPGRADE QC ARRAY TO GLOBAL SCREENING ARRAY (GSA) FOR NCI
-
批准号:10715793
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
ILLUMINA GLOBAL DIVERSITY ARRAY FOR NCI
-
批准号:10715776
-
项目类别:
-
资助金额:$43.52万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
GENOME-WIDE GENOTYPING OF EXISTING SAMPLES FROM ASIAN AMERICAN AND PACIFIC ISLANDER PARTICIPANTS IN THE CALIFORNIA TEACHERS STUDY COHORT
-
批准号:10723615
-
项目类别:
-
资助金额:$170.96万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
GLOBAL DIVERSITY ARRAY (GDA) FOR NCI
-
批准号:10723614
-
项目类别:
-
资助金额:$12.49万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
COLLECTING WHOLE GENOME SEQUENCE DATA TO ENHANCE THE VALUE OF THE FIRST MULTI-CENTER STUDY OF COLORECTAL CANCER RISK FACTORS AND BIOLOGY IN NIGERIA
-
批准号:10723617
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
WHOLE EXOME SEQUENCING, 90% AT 20X IN BLOOD FOR NCI
-
批准号:10715756
-
项目类别:
-
资助金额:$180.66万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
GENOTYPING SERVICES USING ILLUMINA GLOBAL DIVERSITY ARRAY (GDA) FOR NIDCR (FONTANA): Genetic markers of caries risk in diverse underserved children
-
批准号:10710135
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
CIDR – IDENTIFICATION OF MODIFIERS OF 22Q11.2 DELETION SYNDROME BY WHOLE GENOME SEQUENCING IN BLOOD DNA (MORROW)
-
批准号:10709067
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
CIDR - GENOTYPING SERVICES USING WHOLE EXOME SEQUENCING FOR NCI
-
批准号:10723616
-
项目类别:
-
资助金额:$52.43万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
WHOLE EXOME SEQUENCING, 90% AT 20X WITH 1-2% FAILURE RATE (BUCCAL/BLOOD) FOR NCI
-
批准号:10723606
-
项目类别:
-
资助金额:$332.5万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
WHOLE EXOME SEQUENCING (20X) FOR NEI (IYENGAR)
-
批准号:10717161
-
项目类别:
-
资助金额:$125.02万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
ILLUMINA GLOBAL DIVERSITY ARRAY IN BLOOD FOR NCI
-
批准号:10723630
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2022
-
负责人:KIM DOHENY
-
依托单位:
HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE: Whole Genome Sequencing of Bilateral Cleft Lip and Palate families from Africa
-
批准号:10498645
-
项目类别:
-
资助金额:$103.5万
-
财政年份:2021
-
负责人:KIM DOHENY
-
依托单位:
HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE: WHOLE GENOME SEQUENCING, 30X FOR NEI
-
批准号:10506205
-
项目类别:
-
资助金额:$2.9万
-
财政年份:2021
-
负责人:KIM DOHENY
-
依托单位:
HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE: WHOLE EXOME SEQUENCING (20X) FOR NEI
-
批准号:10506204
-
项目类别:
-
资助金额:$63.95万
-
财政年份:2021
-
负责人:KIM DOHENY
-
依托单位:
WHOLE GENOME SEQUENCING 30X (KLEIN) FOR NCI
-
批准号:10291062
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2020
-
负责人:KIM DOHENY
-
依托单位:
GWAS ILLUMINA ONCOARRAY PLUS 20K CUSTOM BEADTYPES (AMOS) FOR NCI
-
批准号:10291065
-
项目类别:
-
资助金额:$346.09万
-
财政年份:2020
-
负责人:KIM DOHENY
-
依托单位:
ILLUMINA HUMANCOREEXOME-24 BEADCHIP ARRAY (GLEESON) FOR NINDS
-
批准号:10285583
-
项目类别:
-
资助金额:$17.25万
-
财政年份:2020
-
负责人:KIM DOHENY
-
依托单位:
GLOBAL SCREENING ARRAY (BRENNAN) FOR NIDCR/NCI
-
批准号:10291057
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2020
-
负责人:KIM DOHENY
-
依托单位:
ILLUMINA GLOBAL DIVERSITY ARRAY (SHAFFER&MARAZITA) NIDCR FY 2020 CAN 8469539: Genetics of Orofacial Clefts, Sub-types, and Subclinical Phenotypes
-
批准号:10275973
-
项目类别:
-
资助金额:$54.6万
-
财政年份:2020
-
负责人:KIM DOHENY
-
依托单位:
国内基金
海外基金
基于 Direct RNA sequencing 的 RNA 甲基化介导贻贝天然免疫调控的表观遗传机制研究
-
批准号:LR22D060002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:祁鹏志
-
依托单位:
全外显子组测序(Whole-Exome Sequencing,WES)检测NSCLC中难治性OCT4+循环肿瘤细胞的基因突变
-
批准号:81773273
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2017
-
负责人:李榕
-
依托单位: